Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol

INTRODUCTION: Treatment of cutaneous and mucosal leishmaniasis (CL and ML, respectively) must be individualised as there is no universal therapeutic approach. Intravenous liposomal amphotericin B (L-AmB) is an accessible and relatively safe treatment that has been increasingly used for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Naeem, Faheel, Nathan, Keren, Chivinski, Jeffrey, Ekmekjian, Taline, Libman, Michael, Barkati, Sapha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211079/
https://www.ncbi.nlm.nih.gov/pubmed/34135039
http://dx.doi.org/10.1136/bmjopen-2020-045707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211079/
https://www.ncbi.nlm.nih.gov/pubmed/34135039
http://dx.doi.org/10.1136/bmjopen-2020-045707

Ejemplares similares